© 2021 MJH Life Sciences and Drug Topics. All rights reserved.
© 2021 MJH Life Sciences™ and Drug Topics. All rights reserved.
December 01, 2021
Sometimes Kawasaki disease doesn’t respond to treatment. An investigation looks into whether a second course of standard treatment performed better than treating with infliximab.
November 30, 2021
The shift to value-based care in the U.S. has been slow in coming, in large part because providers have continued to cling to the traditional “fee for service” healthcare model that historically has worked well for them.
The Omicron variant was first identified in South Africa on November 24, 2021.
The Omicron variant of COVID-19 is spreading quickly, jumping continents through infected travelers. Here’s the latest on what global health officials know.
November 26, 2021
From 1976 to 2018, data show the prevalence of obesity in the United States increased from 6.2% to 32.7%.
November 24, 2021
The commentary urgently calls for pharmacists and pharmacy associations to offer the FDA their feedback on the SUPPORT Act and the potential for a new Risk Evaluation and Mitigation Strategy.
Collaboration among stakeholders is needed to increase transparency of pharmacy payment programs and to better align the design of these models with good patient care.
November 23, 2021
Two key health provisions in the House “BBB “ would empower CMS to negotiate the prices of 10 drugs starting in 2023 and put a limit of $2,000 on Medicare Part D annual out-of-pocket costs.
November 22, 2021
Racial and ethnic inequities persist in all 50 states.
The policy led to $23 million in cost savings within the first 12 months.